Doppman J L, Oldfield E H, Nieman L K
Warren Grant Magnuson Clinical Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.
Ann Intern Med. 1998 Jan 1;128(1):33-6. doi: 10.7326/0003-4819-128-1-199801010-00006.
Bilateral sampling of the petrosal sinuses to distinguish Cushing disease from the ectopic adrenocorticotropic hormone (ACTH) syndrome is accurate but technically demanding and risky. Bilateral sampling of the internal jugular vein is simpler and safer.
To compare bilateral internal jugular vein sampling with bilateral inferior petrosal sinus sampling for distinguishing patients with Cushing disease from those with the ectopic ACTH syndrome.
Tertiary referral hospital.
20 patients with surgically proven Cushing disease and 1 patient with proven ectopic ACTH syndrome.
All patients underwent petrosal sinus sampling and jugular vein sampling before and after administration of corticotropin-releasing hormone (CRH) on separate days.
Ratios of central ACTH to peripheral ACTH in petrosal sinus samples and jugular vein samples were calculated before and after administration of CRH.
Ratios of central to peripheral ACTH were diagnostic for Cushing disease (> 2 before administration of CRH and > 3 after administration of CRH) in jugular vein samples from 16 of 20 patients with surgically proven Cushing disease (sensitivity, 80% [95% CI, 56% to 96%]). Ten of these 16 patients (63%) had diagnostic results only after CRH was administered. The average ratio of central to peripheral ACTH in jugular vein samples was 2.7 before CRH and 7.7 after CRH. Ratios of central to peripheral ACTH were diagnostic in petrosal sinus samples from 19 of 20 patients with surgically proven Cushing disease (sensitivity, 95% [CI, 75% to 99%]). Samples from all 19 patients had diagnostic ratios before and after administration of CRH. The average ratio of central to peripheral ACTH in petrosal sinus samples was 17.7 before CRH and 90.0 after CRH. In the patient with the ectopic ACTH syndrome, ratios of central to peripheral ACTH were negative in jugular vein samples and petrosal sinus samples before and after CRH (< 2 and < 3, respectively).
Jugular vein sampling correctly identified ACTH-secreting pituitary adenomas in 80% of patients with proven Cushing disease. Administration of CRH was essential for diagnostic results in 63% of the patients. Jugular vein sampling is less invasive than petrosal sinus sampling. Negative results on jugular vein sampling should be confirmed by petrosal sinus sampling.
通过双侧岩下窦采样以区分库欣病与异位促肾上腺皮质激素(ACTH)综合征准确无误,但技术要求高且风险大。双侧颈内静脉采样则更简便、安全。
比较双侧颈内静脉采样与双侧岩下窦采样在区分库欣病患者与异位ACTH综合征患者方面的效果。
三级转诊医院。
20例经手术证实为库欣病的患者及1例经证实为异位ACTH综合征的患者。
所有患者在不同日期接受促肾上腺皮质激素释放激素(CRH)给药前后均进行了岩下窦采样和颈静脉采样。
计算CRH给药前后岩下窦样本和颈静脉样本中中心ACTH与外周ACTH的比值。
在20例经手术证实为库欣病的患者中,16例患者的颈静脉样本中中心与外周ACTH的比值可诊断为库欣病(CRH给药前>2,CRH给药后>3)(敏感性为80%[95%CI,56%至96%])。这16例患者中有10例(63%)仅在给予CRH后才获得诊断结果。CRH给药前颈静脉样本中中心与外周ACTH的平均比值为2.7,给药后为7.7。在20例经手术证实为库欣病的患者中,19例患者的岩下窦样本中中心与外周ACTH的比值可诊断疾病(敏感性为95%[CI,75%至99%])。所有19例患者的样本在CRH给药前后均有诊断性比值。CRH给药前岩下窦样本中中心与外周ACTH的平均比值为17.7,给药后为90.0。在异位ACTH综合征患者中,CRH给药前后颈静脉样本和岩下窦样本中中心与外周ACTH的比值均为阴性(分别<2和<3)。
颈静脉采样在80%经证实为库欣病的患者中正确识别出了分泌ACTH的垂体腺瘤。63%的患者中,CRH给药对诊断结果至关重要。颈静脉采样的侵入性低于岩下窦采样。颈静脉采样结果为阴性时,应以岩下窦采样进行确认。